Skip to main content

ADVERTISEMENT

Riya Gandhi, MA, Associate Editor

News
07/31/2023
Riya Gandhi, MA, Associate Editor
A multidisciplinary workgroup has released updated guidelines for the management of atopic dermatitis (AD) in adults using topical therapies in a study published in the Journal of the American Academy of Dermatology.
A multidisciplinary workgroup has released updated guidelines for the management of atopic dermatitis (AD) in adults using topical therapies in a study published in the Journal of the American Academy of Dermatology.
A multidisciplinary workgroup...
07/31/2023
The Dermatologist
News
07/31/2023
Riya Gandhi, MA, Associate Editor
According to a recent study shedding light on the underlying immune mechanisms of nummular eczema, researchers have revealed that this common chronic inflammatory skin disease exhibits a dual immune response, with features resembling both...
According to a recent study shedding light on the underlying immune mechanisms of nummular eczema, researchers have revealed that this common chronic inflammatory skin disease exhibits a dual immune response, with features resembling both...
According to a recent study...
07/31/2023
The Dermatologist
News
07/31/2023
Riya Gandhi, MA, Associate Editor
A recent study revealed that upadacitinib was well tolerated and did not pose any new significant safety risks when used to treat atopic dermatitis.
A recent study revealed that upadacitinib was well tolerated and did not pose any new significant safety risks when used to treat atopic dermatitis.
A recent study revealed that...
07/31/2023
The Dermatologist
News
07/06/2023
Riya Gandhi, MA, Associate Editor
In a recent systematic review and meta-analysis published in the Journal of Allergy and Clinical Immunology, researchers provided evidence supporting the benefits of allergen immunotherapy for the treatment of atopic dermatitis.
In a recent systematic review and meta-analysis published in the Journal of Allergy and Clinical Immunology, researchers provided evidence supporting the benefits of allergen immunotherapy for the treatment of atopic dermatitis.
In a recent systematic review...
07/06/2023
The Dermatologist
News
07/06/2023
Riya Gandhi, MA, Associate Editor
In a recent study, researchers provided valuable insights into the diagnosis and treatment of atopic dermatitis in both children and adults based on current German and European guidelines.
In a recent study, researchers provided valuable insights into the diagnosis and treatment of atopic dermatitis in both children and adults based on current German and European guidelines.
In a recent study, researchers...
07/06/2023
The Dermatologist
News
07/06/2023
Riya Gandhi, MA, Associate Editor
In a recent study published in RMD Open, the long-term safety profile of upadacitinib, a medication utilized in the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD),...
In a recent study published in RMD Open, the long-term safety profile of upadacitinib, a medication utilized in the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD),...
In a recent study published in...
07/06/2023
The Dermatologist
NPF Endorsed Features
06/12/2023
Riya Gandhi, MA, Associate Editor
This multiday virtual event offered practical, timely education that attendees can immediately translate into positive patient outcomes.
This multiday virtual event offered practical, timely education that attendees can immediately translate into positive patient outcomes.
This multiday virtual event...
06/12/2023
The Dermatologist
Emily Ruiz, MD, MPH
Videos
05/31/2023
Riya Gandhi, MA, Associate Editor
In this interview, Dr Emily Ruiz discusses her session, “Pro and Con: Contentious Concepts,” at the 2023 ACMS Annual Meeting. She covered the topic, “Mohs vs Topical Therapy for Squamous Cell Carcinoma in Situ: Pro Topical Therapy.”
In this interview, Dr Emily Ruiz discusses her session, “Pro and Con: Contentious Concepts,” at the 2023 ACMS Annual Meeting. She covered the topic, “Mohs vs Topical Therapy for Squamous Cell Carcinoma in Situ: Pro Topical Therapy.”
In this interview, Dr Emily Ruiz...
05/31/2023
The Dermatologist
Addison M. Demer, MD
Q&As
05/31/2023
Riya Gandhi, MA, Associate Editor
In this interview, Dr Addison Demer discusses the session he moderated, “Mohs for Melanoma Immunohistochemistry Refresher,” at the 2023 ACMS Annual Meeting.
In this interview, Dr Addison Demer discusses the session he moderated, “Mohs for Melanoma Immunohistochemistry Refresher,” at the 2023 ACMS Annual Meeting.
In this interview, Dr Addison...
05/31/2023
The Dermatologist
Justin Leitenberger
Q&As
05/31/2023
Riya Gandhi, MA, Associate Editor
In this interview, Dr Leitenberger discusses his session, “Mohs for Melanoma Immunohistochemistry (IHC) Refresher,” at the 2023 ACMS Annual Meeting. He covered the topic, “Mohs IHC Interpretation.”
In this interview, Dr Leitenberger discusses his session, “Mohs for Melanoma Immunohistochemistry (IHC) Refresher,” at the 2023 ACMS Annual Meeting. He covered the topic, “Mohs IHC Interpretation.”
In this interview, Dr...
05/31/2023
The Dermatologist